The Claim

In glucose-deprived A549 lung adenocarcinoma cells, elevated expression of PCK2 activates the AMPK–CEBPB signaling axis, which increases the expression of SLC38A2, enhances glutamine utilization, elevates glycolytic output, and increases cell proliferation, migration, and invasion.

Source: Phosphoenolpyruvate carboxykinase 2 activation of the AMPK–CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
48score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In lung cancer cells starved of glucose, higher levels of the PCK2 protein trigger a chain of molecular signals that increase the uptake and use of glutamine, boost sugar breakdown for energy, and cause the cells to multiply and spread more aggressively.

See the scientific wording

In glucose-deprived A549 lung adenocarcinoma cells, elevated expression of PCK2 activates the AMPK–CEBPB signaling axis, leading to increased expression of the glutamine transporter SLC38A2, enhanced glutamine utilization, elevated glycolytic output, and increased cell proliferation, migration, and invasion, suggesting a metabolic adaptation mechanism critical for tumor survival under nutrient stress.

Why this might work

When glucose is scarce, cells turn on PCK2, which activates AMPK, which turns on CEBPB, which tells the cell to make more glutamine transporters. More glutamine enters the cell, gets converted into molecules that keep the energy factory running and feed sugar production, allowing the cell to keep growing, moving, and spreading even without glucose.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Phosphoenolpyruvate carboxykinase 2 activation of the AMPK–CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation

    When lung cancer cells don't get enough glucose, they turn on a molecular switch (PCK2) that tells them to grab more glutamine, which they use to make energy and grow more aggressively. The study proved this exact chain of events happens in the lab.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.